The Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4FY 24 grew by 37% YoY to Rs 551 crore. The net debt on March 31 stood at Rs 2700 crore.
from Stocks-Markets-Economic Times https://ift.tt/DYutZi2
Home »
Stocks-Markets-Economic Times
» Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
Related Posts:
Adani Transmission to raise $1.15b via offshore loans“The company is working on a dedicated structure through which the whole sum will be raised for those four projects,” said one of the people. The four include the Western Region Strengthening Scheme, Lakadia Banaskantha Trans… Read More
Cairn tracks $70 billion foreign assets"The Indian government naturally will challenge such seizure but to save the assets it may have to pawn money equivalent to the value of assets in some financial security such as bank guarantee. The court will return such a g… Read More
Saurabh Mukherjea is hoping his next big bet will turn out to be a multibaggerShareholding pattern of the stock reveals retail investors are yet to discover this gem even though four mutual funds have lapped it up already. The speciality chemicals stock is part of Saurabh Mukherjea's Little Champs port… Read More
Caught short strategists are a stealth stock market accelerantWhile nobody believes the published opinions of strategists are particularly meaningful to the day-to-day motion of share prices, the phenomenon illustrates a dynamic that’s been supporting equities for more than a year. fro… Read More
RBI raises concerns over dual microfinance regulation in AssamDuring the first meeting of the newly formed Assam government and microfinance stakeholders in Guwahati on Saturday, RBI officials are said to have argued that banks and non-bank microlenders, which are regulated by it and op… Read More
0 Comments:
Post a Comment